![CDDF Annual Conference 2024 – Key Takeaways from Session 3: Decentralized Care and Trials](https://cddf.org/wp-content/uploads/2024/02/Untitled-design-16-1080x675.jpg)
![CDDF Annual Conference 2024 – Key Takeaways from Session 3: Decentralized Care and Trials](https://cddf.org/wp-content/uploads/2024/02/Untitled-design-16-1080x675.jpg)
![CDDF Annual Conference 2024 – Key Takeaways from Session 1: Real World Evidence](https://cddf.org/wp-content/uploads/2024/02/Selected_IMG_1024-1080x675.jpg)
CDDF Annual Conference 2024 – Key Takeaways from Session 1: Real World Evidence
The first day of the CDDF Annual Conference 2024 generated highly productive and vibrant dialogue around critical questions about real world evidence and underscoring the importance of collaborative efforts. Here are the key takeaways from Session 1: Real World...![Key Takeaways from the CDDF Webinar on COVID-19 and Cancer – Time for a Reset to Repair the Damage Done](https://cddf.org/wp-content/uploads/2024/01/sssss-1080x675.jpg)
Key Takeaways from the CDDF Webinar on COVID-19 and Cancer – Time for a Reset to Repair the Damage Done
The Cancer Drug Development Forum (CDDF) held a live webinar on “COVID-19 and Cancer – Time for a Reset to repair the damage done “ on Monday 15 January 2024 at 17:00 (CET) / 11:00 (EST). In this webinar, Mark Lawler (Queen’s University Belfast & CDDF), Ajay...![The CDDF Engages at the Accelerating Global Health Equity Annual Summit](https://cddf.org/wp-content/uploads/2024/01/89d8e6a5-42b4-4ab2-95d7-f4354e689228-1080x675.jpeg)
The CDDF Engages at the Accelerating Global Health Equity Annual Summit
Dr. Catarina Edfjäll, representing the CDDF, participated in a panel discussion on EU Pharmaceutical Legislation at the Accelerating Global Health Equity Annual Summit, held as a World Economic Forum (WEF) side event in Davos on January 18, 2024. Dr. Edfjäll joined...![CDDF’s Selection As Ad Hoc Representative of the Multi-Stakeholder Platform Advisory Group (MSP AG) Under the Accelerating Clinical Trials in the EU (ACT EU)](https://cddf.org/wp-content/uploads/2024/01/Copy-of-Dark-Purple-and-Blue-Texture-Blur-Circle-Business-Marketing-Presentation-1080x675.jpg)
CDDF’s Selection As Ad Hoc Representative of the Multi-Stakeholder Platform Advisory Group (MSP AG) Under the Accelerating Clinical Trials in the EU (ACT EU)
The Cancer Drug Development Forum is proud to announce its selection as an ad hoc representative of the Multi-Stakeholder Platform Advisory Group (MSP AG) under the Accelerating Clinical Trials in the EU (ACT EU). The ACT EU initiative is run by the European...![Gain valuable perspectives from CDDF participants and get an inside look at the CDDF Multi-stakeholder workshop on Biomarkers in Precision Oncology (Nov 2023)](https://cddf.org/wp-content/uploads/2024/01/Capture-1080x675.jpg)